Jump Financial’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-22,200
Closed -$27.3K – 2538
2026
Q2
$27.3K Buy
+22,200
New +$22.1K ﹤0.01% 1952
2026
Q1
– Sell
-10,631
Closed -$16.5K – 2221
2025
Q4
$16.5K Buy
+10,631
New +$17K ﹤0.01% 1886
2022
Q1
– Sell
-20,500
Closed -$209K – 1777
2021
Q4
$209K Buy
+20,500
New +$220K 0.01% 1094

Other funds holding MXCT

Jump Financial's MXCT Position: Q3 2026 in Review

Jump Financial sold out of MaxCyte (MXCT) in Q3 2026, closing a stake of 22,200 shares — an estimated $27.3K sold.

Jump Financial first reported a position in MXCT in Q4 2021 and held it in 3 quarters. The position peaked at $209K in Q4 2021. 119 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.

  • Jump Financial reported no remaining MaxCyte position as of Q3 2026 after selling out during the quarter.
  • Jump Financial sold 22,200 MaxCyte shares in Q3 2026, an estimated $27.3K.
  • Jump Financial first reported a position in MaxCyte in Q4 2021 and held it in 3 quarters.
  • Jump Financial's MaxCyte position peaked at $209K in Q4 2021.
  • 119 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.